Protalix BioTherapeutics (Israel)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Immunology and Microbiology 15.7×
• Chemistry 8.1×
• Biochemistry, Genetics and Molecular Biology 3.1×
• Medicine 1.7×
• Computer Science 1.1×
• Social Sciences 1.0×
• Materials Science 0.2×
• Agricultural and Biological Sciences 0.1×

By fractional works in all years, weighted toward what it does more of than the world: Enzyme Replacement Therapy, Lysosomal Storage Disorders, Biopharmaceuticals, Plant Molecular Farming, Recombinant Proteins, Immune Response, Glycosylation and Glycosidase Inhibitors.

By volume in 2022–2025: Lysosomal Storage Disorders Research, Computational Drug Discovery Methods, Melanoma and MAPK Pathways and Advanced Proteomics Techniques and Applications.

1. 1 Lysosomal Storage Disorders Research Physiology 1 works
2. 2 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
3. 3 Melanoma and MAPK Pathways Molecular Biology 0 works
4. 4 Advanced Proteomics Techniques and Applications Spectroscopy 0 works
5. 5 Neutrophil, Myeloperoxidase and Oxidative Mechanisms Immunology 0 works
6. 6 Literature, Language, and Rhetoric Studies Sociology and Political Science 0 works
7. 7 European Cultural and National Identity Sociology and Political Science 0 works
8. 8 Carbohydrate Chemistry and Synthesis Organic Chemistry 0 works
9. 9 Immune cells in cancer Immunology 0 works
10. 10 Microbial metabolism and enzyme function Molecular Biology 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 44% lower than in 2013–2017.

• Braude College of Engineering Karmiel
• Carl Zeiss (Israel)
• Israel Olive Oil Board